These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16113463)

  • 1. Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment.
    Higenbottam T
    Proc Am Thorac Soc; 2005; 2(1):12-9. PubMed ID: 16113463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation.
    Pepin V; Saey D; Laviolette L; Maltais F
    COPD; 2007 Sep; 4(3):195-204. PubMed ID: 17729063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of hyperinflation by pharmacologic and other interventions.
    Casaburi R; Porszasz J
    Proc Am Thorac Soc; 2006 Apr; 3(2):185-9. PubMed ID: 16565430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
    Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD management. Part I. Strategies for managing the burden of established COPD.
    Jenkins C
    Int J Tuberc Lung Dis; 2008 Jun; 12(6):586-94. PubMed ID: 18492322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End stage chronic obstructive pulmonary disease.
    Ambrosino N; Gherardi M; Carpenè N
    Pneumonol Alergol Pol; 2009; 77(2):173-9. PubMed ID: 19462352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
    Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
    Zuwallack RL; Nici L
    COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease.
    Belfer MH; Reardon JZ
    J Am Osteopath Assoc; 2009 May; 109(5):268-78; quiz 280-1. PubMed ID: 19451260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.
    Cukier A; Ferreira CA; Stelmach R; Ribeiro M; Cortopassi F; Calverley PM
    Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and management of chronic obstructive pulmonary disease].
    Sato N; Kanazawa M
    Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
    Corte TJ; Wort SJ
    Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the role of activity, exercise, and pharmacology in mild COPD.
    O'Donnell DE; Gebke KB
    Postgrad Med; 2014 Sep; 126(5):135-45. PubMed ID: 25295658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease.
    Deschênes D; Pepin V; Saey D; LeBlanc P; Maltais F
    J Cardiopulm Rehabil Prev; 2008; 28(3):208-14. PubMed ID: 18496322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in chronic obstructive pulmonary disease.
    Barnes PJ
    Trans Med Soc Lond; 2002-2003; 119():41-51. PubMed ID: 17184031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part I: Identifying chronic obstructive pulmonary disease in patients with respiratory symptoms.
    Sussman R
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S5-12. PubMed ID: 17925063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.